Delivery Order SPE2DB20D3103-SPE2DB25FQ0C0
- Not listed
- The Defense Logistics Agency awarded a $2,372.46 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,374.34 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count supply) with a ceiling value of $2,574.31 under a firm fixed price contract. The award was made on August 20, 2025, with ultimate completion targeted for August 21, 2025. This delivery order represents a non-set-aside, competitively awarded contract and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location, the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,628.05 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count packaging) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract utilizes firm fixed-price pricing and was awarded on a non-set-aside, competitive basis. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,047.33 delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (90-count units) on August 18, 2025, with completion due by August 19, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical products to be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,255.57 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30. The contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,163.04 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count units) on July 30, 2025, with an ultimate completion date of July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,722.99 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with performance expected to be completed by August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count) with a ceiling value of $3,690.52. This competitive contract, issued under a firm fixed-price delivery order structure, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a $1,436.96 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Terbinafine HCL 250 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ0C0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,848.05 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX). The performance location is the contractor's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies comprehensive pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order for terbinafine, an antifungal medication, exemplifies the company's role in fulfilling DLA's pharmaceutical supply requirements. The company maintains a $999,999,999.00 indefinite delivery vehicle through December 2026 that enables it to supply pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities globally to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 8/25/25 |